MedPath

Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease.

Not Applicable
Conditions
untreated mild diabetic patients (HbA1c&lt
7.0%) and impaired glucose tolearence
Registration Number
JPRN-UMIN000011265
Lead Sponsor
Hyogo Brain and Heart Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

chronic renal failure (Cr>2.0mg/dL) steroid user chronic inflammatory disease (infection, collagen disease, malignant disease)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath